Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

被引：0
作者：
Xu-Kai Wang
Ye Zhang
Cheng-Ming Yang
Yan Wang
Guang-Yao Liu
机构：
[1] Third Military Medical University,Cardiovascular Department, Daping Hospital
来源：
Clinical Drug Investigation | 2006年 / 26卷
关键词：
Coronary Artery Bypass Graft; Acute Myocardial Infarction; Enoxaparin; Thrombolytic Therapy; Anticoagulation Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Acute myocardial infarction (AMI) is one of the most serious cardiovascular diseases, with acute ST-segment elevation myocardial infarction (STEMI) showing a higher mortality rate than non-ST-segment elevation myocardial infarction (NSTEMI). There is evidence that low-molecular-weight heparin (LMWH) shows greater efficacy than unfractionated heparin (UFH). This open-label, single-centre, randomised study was conducted to compare the efficacy and safety of parnaparin sodium, a LMWH, with UFH in patients with STEMI.
引用
收藏
页码：341 / 349
页数：8
相关论文
共 67 条
  • [1] Gao Y.Q.(2002)Relation of the ST-segment elevation pattern in acute phase of anterior wall acute myocardial infarction to short-term prognosis Di Yi Jun Yi Da Xue Xue Bao 22 156-8
  • [2] Li Z.L.(2001)Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 605-13
  • [3] Ding M.X.(2002)Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation 105 1642-9
  • [4] Antman E.M.(2002)Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction Eur Heart J 23 627-32
  • [5] Louwerenburg H.W.(2000)Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Am J Cardiol 86 553-6
  • [6] Baars H.F.(2003)The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial J Am Coll Cardiol 42 1348-56
  • [7] Baird S.H.(2003)Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction Am J Cardiol 91 860-4
  • [8] Menown I.B.(2003)Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 135-42
  • [9] McBride S.J.(2002)Haemodialysis hypotension and nitric oxide production: comparison of heparin with parnaparin Blood Purif 20 145-9
  • [10] Cohen M.(1994)Thromboembolic disease: prevention with low-molecular weight heparin in general surgery. Preliminary results [in Italian] Minerva Chir 49 585-9
1234567